ZNF839 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.229800E-01
Normal-vs-Stage2
3.511400E-01
Normal-vs-Stage3
1.029370E-01
Normal-vs-Stage4
2.572200E-01
Stage1-vs-Stage2
3.518800E-01
Stage1-vs-Stage3
1.680990E-01
Stage1-vs-Stage4
4.697400E-01
Stage2-vs-Stage3
9.460100E-02
Stage2-vs-Stage4
8.811200E-01
Stage3-vs-Stage4
1.636160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.743500E-02
Normal-vs-AfricanAmerican
2.982200E-01
Normal-vs-Asian
3.251200E-01
Caucasian-vs-AfricanAmerican
5.969800E-02
Caucasian-vs-Asian
3.605800E-01
AfricanAmerican-vs-Asian
7.259400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.819400E-01
Normal-vs-Female
7.256300E-02
Male-vs-Female
6.518000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.311600E-01
Normal-vs-Age(41-60Yrs)
4.107000E-01
Normal-vs-Age(61-80Yrs)
3.664800E-01
Normal-vs-Age(81-100Yrs)
4.042000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.745400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.435400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.697800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.726000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.084600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.994400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.612800E-01
Normal-vs-Daily Drinker
2.249400E-01
Normal-vs-Weekly Drinker
3.141200E-01
Normal-vs-Occasional Drinker
1.698240E-01
Normal-vs-Social Drinker
2.016200E-01
Non Drinker-vs-Daily Drinker
4.230400E-01
Non Drinker-vs-Weekly Drinker
4.628000E-01
Non Drinker-vs-Occasional Drinker
2.786600E-01
Non Drinker-vs-Social Drinker
2.952000E-01
Daily Drinker-vs-Weekly Drinker
2.583400E-01
Daily Drinker-vs-Occasional Drinker
9.270400E-01
Daily Drinker-vs-Social Drinker
9.147000E-01
Weekly Drinker-vs-Occasional Drinker
1.525840E-01
Weekly Drinker-vs-Social Drinker
1.685360E-01
Occasional Drinker-vs-Social Drinker
9.800800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.268800E-01
Normal-vs-Grade 2
3.342000E-01
Normal-vs-Grade 3
2.511600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.657600E-02
Grade 1-vs-Grade 3
3.244300E-02
Grade 1-vs-Grade 4
3.268800E-01
Grade 2-vs-Grade 3
8.601200E-01
Grade 2-vs-Grade 4
3.342000E-01
Grade 3-vs-Grade 4
2.511600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.507600E-01
Normal-vs-NonDiabetic
8.871900E-02
Diabetic-vs-NonDiabetic
2.365600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.941600E-01
Normal-vs-NoPancreatitis
5.904100E-02
Pancreatitis-vs-NoPancreatitis
3.685800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.284250E-01
Normal-vs-N1
3.421400E-01
N0-vs-N1
4.506300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.220600E-01
Normal-vs-TP53-NonMutant
4.728600E-01
TP53-Mutant-vs-TP53-NonMutant
3.055700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
